GRX-54

N/A

Report date: 2026/04/20 20:01:59

Base Information

Drug NameGRX-54
Drug Alias NameGRX-54
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide aptamer > Raptamer-drug conjugates
Mechanisms of ActionAnti-Glypican-3Wnt signalling pathway inhibitors
TargetsGlypican-3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGuardian Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesGuardian Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A